$14.88
-1.13 (-7.06%)
Open$15.69
Previous Close$16.01
Day High$15.90
Day Low$14.27
52W High$209.03
52W Low$2.29
Volume—
Avg Volume599.4K
Market Cap9.84M
P/E Ratio—
EPS$-294.14
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 30.53M | 777.7K | 707.3K |
| Net Income | -149,480,499 | 128.9K | 94.3K |
| Profit Margin | -489.6% | 16.6% | 13.3% |
| EBITDA | -146,527,020 | 197.3K | 212.4K |
| Free Cash Flow | — | 80.3K | 76.9K |
| Rev Growth | +172.4% | -2.7% | +7.8% |
| Debt/Equity | 0.08 | 0.46 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,127.69 | +0.93% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $244.88 | +1.61% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $125.45 | +4.02% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.67 | -1.54% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.39 | +0.71% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.82 | -0.45% | 12.5 | 33.00B |